Moreno Santiago, Antela Antonio, García Felipe, Del Amo Julia, Boix Vicente, Coll Pep, Fortuny Claudia, Sirvent Juan L Gómez, Gutiérrez Félix, Iribarren José A, Llibre Josep M, Quirós Juan C López Bernaldo de, Losa Juan Emilio, Lozano Ana, Meulbroek Michael, Olalla Julián, Pujol Ferran, Pulido Federico, Crespo Casal Manuel, García Juan González, Aldeguer José López, Molina Jose A Pérez, Podzamczer Palter Daniel, Román Antonio Rivero
Hospital Universitario Ramón y Cajal, Madrid, Spain.
Hospital Clínico Universitario, Santiago de Compostela, Spain.
Enferm Infecc Microbiol Clin. 2017 Jun-Jul;35(6):377-383. doi: 10.1016/j.eimc.2016.11.016. Epub 2017 Feb 22.
Administration of antiretroviral drugs to individuals exposed to, but not infected by, HIV has been shown to reduce the risk of transmission. The efficacy of pre-exposure prophylaxis (PrEP) makes it obligatory to include it in an integral program of prevention of HIV transmission, together with other measures, such as use of the condom, training, counseling, and appropriate treatment of infected individuals. In this document, the AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica [SEIMC]) provides its views on this important subject. The available evidence on the usefulness of PrEP in the prevention of transmission of HIV is presented, and the components that should make up a PrEP program and whose development and implementation are feasible in Spain are set out.
对暴露于艾滋病毒但未被感染的个体使用抗逆转录病毒药物已被证明可降低传播风险。暴露前预防(PrEP)的有效性使其必须被纳入艾滋病毒传播综合预防计划,与其他措施,如使用避孕套、培训、咨询以及对感染者进行适当治疗一起。在本文件中,西班牙传染病和临床微生物学会(Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica [SEIMC])的艾滋病研究小组(GeSIDA)就这一重要主题发表了看法。文中介绍了关于PrEP在预防艾滋病毒传播方面有用性的现有证据,并阐述了构成PrEP计划且在西班牙其开发和实施可行的组成部分。